Per dose, at full retail price, Axiron is about double the cost of androgel. Accordingly, the big insurers are more likely to target Axiron for rebates than Androgel.
That said, Axiron is a superior and safer product, so it should always be priced at a premium to Androgel. This fall in sales could have more to do with cost cutting at the big insurers than it has to do with the FDA labelling.
- Forums
- ASX - By Stock
- Not good figures
ACR
acrux limited
Add to My Watchlist
5.26%
!
1.8¢

Per dose, at full retail price, Axiron is about double the cost...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.8¢ |
Change
-0.001(5.26%) |
Mkt cap ! $7.339M |
Open | High | Low | Value | Volume |
1.9¢ | 1.9¢ | 1.8¢ | $11.58K | 619.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 335415 | 1.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.9¢ | 516258 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 335415 | 0.018 |
1 | 175000 | 0.017 |
1 | 66732 | 0.015 |
1 | 70000 | 0.014 |
1 | 297000 | 0.013 |
Price($) | Vol. | No. |
---|---|---|
0.019 | 516258 | 1 |
0.020 | 80000 | 3 |
0.021 | 177000 | 1 |
0.022 | 118000 | 2 |
0.023 | 73278 | 3 |
Last trade - 16.10pm 23/06/2025 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |